What kind of deal should we do with an external partner to optimize the potential for success of our Phase II compound

What kind of deal should we do with an external partner to optimize the potential for success of our Phase II compound? - Partnering Strategy


Life Sciences

Situation

 

  • Mid-sized pharma company with a key strategic asset in Phase II
  • Seeking a partner for Phase III development and marketing/promotion in specified territories
  • Sought help to define an optimal partnering strategy

Actions

 

  • Worked with the board of directors to define a strategy to cover:
    • Deal objectives
    • Partner selection
    • Deal construct
    • Alliance construct
  • Benchmarked against a range of recent deals in the sector
  • Also defined a deal management process, specifying key process stages, milestones and accountabilities

Results

 

  • Increased clarity of and alignment behind corporate objectives for the deal
  • Process revealed a number of weaknesses in the existing clinical development plan which needed to be rectified in advance of any approach to potential partners
  • Asset was eventually partnered with a US company